Company intelligence / Profile preview

Institute Hyalual

Rotkreuz, Zug, Switzerland

Ownership: Private
Employees: ~352
Development stage: Other

Overview

Institute Hyalual markets CE-marked injectable, topical, and device-based aesthetic products for skin rejuvenation, anti-aging, correction and restoration. Their portfolio includes hyaluronic acid fillers, fractional skin rejuvenation therapies, peels, sprays, dermarollers, and combined filler/toxin treatments. The company conducts clinical and post-market research in dermatology and skin aesthetic procedures, presenting at international congresses and publishing studies.

Therapeutic areas: Dermatology
Modalities: BiologicDeviceSmall moleculePeptides
Industry: Therapeutic Medical Devices

Partnerships

Professional medical distributors in over 20 countriespartner manufacturing plants in Switzerland, Spain, USA

Beyond the preview

Go deeper on Institute Hyalual.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Institute Hyalual.

Explore the full profile